PPP6C anticorps

N° du produit ABIN7118034

Détail du produit anti-PPP6C anticorps

Antigène: PPP6C (Protein Phosphatase 6, Catalytic Subunit (PPP6C))

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PPP6C est non-conjugé

Application: Western Blotting (WB), ELISA

Purification: Immunogen affinity purified

Pureté: ≥95 % as determined by SDS-PAGE

Immunogène: protein phosphatase 6, catalytic subunit

Isotype: IgG

Information d'application

Indications d'application: WB: 1:500-1:2000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

Date de péremption: 12 months

Détails sur PPP6C

Antigène: PPP6C (Protein Phosphatase 6, Catalytic Subunit (PPP6C))

Autre désignation: PPP6C (PPP6C Produits)

Synonymes: anticorps PP6, anticorps PP6C, anticorps 2310003C10Rik, anticorps zgc:56227, anticorps ppp6c, anticorps PPP6C, anticorps pp6, anticorps MGC114734, anticorps DDBDRAFT_0168786, anticorps DDBDRAFT_0185210, anticorps DDB_0168786, anticorps DDB_0185210, anticorps CG12217, anticorps DmPpV-6A, anticorps Dmel\\CG12217, anticorps PPPV6A, anticorps PPV, anticorps PPV 6A, anticorps Ppv, anticorps dPP6, anticorps protein phosphatase 6 catalytic subunit, anticorps protein phosphatase 6, catalytic subunit, anticorps protein phosphatase 6, catalytic subunit L homeolog, anticorps serine/threonine-protein phosphatase 6 catalytic subunit, anticorps Protein phosphatase V, anticorps PPP6C, anticorps Ppp6c, anticorps ppp6c, anticorps ppp6c.L, anticorps ppp6C, anticorps PpV

Sujet: Synonyms:PPP6 Background:Catalytic subunit of protein phosphatase 6(PP6). PP6 is a component of a signaling pathway regulating cell cycle progression in response to IL2 receptor stimulation. N-terminal domain restricts G1 to S phase progression in cancer cells, in part through control of cyclin D1. Downregulates MAP3K7 kinase activation of the IL1 signaling pathway by dephosphorylation of MAP3K7.

Poids moléculaire: 35 kDa

ID gène: 5537

UniProt: O00743